Related Experiment Video
Updated: Jun 13, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent
Sandra Barisic1, Claudia Schmidt, Henning Walczak
1Institute of Cell Biology and Immunology, University of Stuttgart, Germany. Sandra.Barisic@izi.uni-stuttgart.de
Abstract:
Activation status of Tyr-kinase Src as well as of the transcription factor NFkappaB is a decisive criterion for the onset of cancer and in conveying radio-resistance. While the activation status of Src is Tyr phosphorylation-dependent, NFkappaB activation requires Ser phosphorylation of its cytosolic inhibitor, IkappaBalpha. Since constitutive NFkappaB activation was linked to tumor maintenance, its tight regulation is mandatory. We provide evidence that inhibition of pan-Tyr phosphatase activity by orthovanadate is translated via Src to inhibition of Ser phosphatase PP2A, thereby changing the physiologic response of the cell. In particular we unravelled a new sequence of molecular interactions linking initial activating Tyr416 phosphorylation of Src not to Tyr42-dependent phosphorylation and degradation of IkappaBalpha, but to sustained Ser177/181 phosphorylation of IkappaBalpha kinase IKKbeta following IL-1 stimulation. Consequently, sustained IKKbeta activation provides for chronic canonical IkappaBalpha degradation, thereby eliciting constitutive NFkappaB activation. As the critical translator of Tyr to Ser phosphorylation we identified Ser/Thr phosphatase PP2A. We show that the catalytic subunit PP2Ac serves as a Src substrate with Tyr307 phosphorylation leading to its catalytic inhibition. Additionally to the known survival pathways triggered by Src, Src-mediated canonical and persistent NFkappaB activation may fortify its tumorigenic effects.
Insights
This study reveals how Src kinase influences cancer by linking tyrosine and serine phosphorylation. It shows Src-mediated inhibition of PP2A phosphatase leads to sustained NFkappaB activation, promoting tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Src kinase and NFkappaB are crucial in cancer development and radio-resistance.
- NFkappaB activation depends on the serine phosphorylation of its inhibitor, IkappaBalpha.
- Constitutive NFkappaB activation is linked to tumor maintenance, necessitating strict regulation.
Purpose of the Study:
- To investigate the molecular mechanisms linking tyrosine and serine phosphorylation in cellular signaling.
- To elucidate the role of Src kinase and PP2A phosphatase in regulating NFkappaB activation.
- To understand how these pathways contribute to cancer progression and tumorigenic effects.
Main Methods:
- Utilized orthovanadate to inhibit pan-tyrosine phosphatase activity.
- Investigated molecular interactions using IL-1 stimulation.
- Analyzed phosphorylation events on Src, IkappaBalpha, and IKKbeta.
- Identified PP2A as a Src substrate and assessed its catalytic activity.
Main Results:
- Inhibition of tyrosine phosphatase activity via Src leads to the inhibition of serine phosphatase PP2A.
- Src-mediated phosphorylation of PP2Ac at Tyr307 inhibits its catalytic activity.
- Src links initial Tyr416 phosphorylation to sustained Ser177/181 phosphorylation of IKKbeta.
- This results in chronic IkappaBalpha degradation and constitutive NFkappaB activation, enhancing tumorigenic effects.
Conclusions:
- PP2A phosphatase acts as a critical mediator translating tyrosine to serine phosphorylation.
- Src-mediated activation of NFkappaB contributes significantly to its tumorigenic potential.
- Targeting the Src-PP2A-NFkappaB axis may offer new therapeutic strategies for cancer treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Receptor Tyrosine Kinases
cAMP-dependent Protein Kinase Pathways

